Prof Michael Dickinson
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
327 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Exploration of experience and sustained engagement with a web-based cognitive rehabilitation intervention amongst patients with aggressive lymphoma: a qualitative sub-study
DOI: 10.1007/s00520-026-10928-z2026
Journal article
Glofitamab monotherapy in patients with Richter transformation: safety and efficacy from a phase 1 study
DOI: 10.1182/bloodadvances.20250181592026
Journal article
Fixed-duration glofitamab monotherapy in relapsed/refractory (R/R) mantle cell lymphoma (MCL) with/without prior Bruton's tyrosine kinase inhibitor (BTKi) exposure: Updated data after a 3.5-year follow-up.
DOI: 10.1200/jco.2026.44.16_suppl.70062026
Journal article
Choosing between Nivo-AVD and BrECADD: Hodgkin lymphoma's new era
DOI: 10.1111/bjh.704512022
Research grants (other domestic)
Novel Strategies to Predict and Monitor Response to CAR T-Cell Therapy in DLBCL
2019
Journal article
Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma
DOI: 10.1111/bjh.160692017
Research Grant
Targeting Epigenetic Enzymes in Core Binding Factor Aml
RECENT SCHOLARLY WORKS
2026
Journal article
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18–65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
DOI: 10.1016/S0140-6736(26)00362-42026
Journal article
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma
DOI: 10.1182/blood.20250323072026
Journal article
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.
DOI: 10.1182/bloodadvances.20260201232026
Journal article
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.
DOI: 10.1182/bloodadvances.20260200122026
Journal article
Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries
DOI: 10.1182/blood.20250308722026
Journal article
Web-Based Cognitive Rehabilitation for Patients With Aggressive Lymphoma With Perceived Cognitive Impairment: A Randomised Pilot Study
DOI: 10.1002/pon.70469